Clinical Trial

Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome

Study acronym: PCOS
Completed Phase 1
View on ClinicalTrials.gov →
Summary
Polycystic Ovarian Syndrome (PCO) is a metabolic disorder that afflicts the women of childbearing age. An approximate of 5-10% women are the victim of this disorder. PCOS is a leading cause of infertility in females these days and is characterized by Hyperandrogenism, Chronic Anovulation, Impaired fertility, obesity, Hirsutism, Acne, Obesity, Metabolic disturbances (dyslipidemias, Hyperinsulinemia, insulin resistance, and type- 2 diabetes), and Endometrial Hyperplasia. This study will test a combination of herbal medications (Melats P) in women with PCOS to determine which works best to overcome infertility.
Protocol Amendment History 1 change
critical Trial completed 2026-06-24
Trial Details
NCT Number NCT07399535
Lead Sponsor Jinnah Postgraduate Medical Centre
Conditions Polycystic Ovarian Syndrome (PCOS), Herbal Medicine, Infertility, Metabolic Disorder
Enrollment 116 participants
Start Date 2025-02-22
Primary Completion 2026-02-22 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23